epipen
Mylan hit with fresh lawsuit over EpiPen pricing
April 4, 2017Manufacturing and Production, Sales and Marketing Mylan, epipen, pricing
Just as it faces worldwide reports that over 80,000 of its EpiPens do not function properly and as the FDA …
FDA issues US-wide recall of Mylan’s EpiPen
April 3, 2017Medical Communications, Sales and Marketing FDA, Mylan, epipen
After recent reports of around 80,000 defective EpiPen’s across Australia, New Zealand, Japan, Norway, Denmark, Finland and Ireland, the FDA …
Rival to EpiPen to be made available to many for free
January 23, 2017Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival
Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …
Drugstore chain CVS offers EpiPen generic for 600% cheaper
January 12, 2017Medical Communications, Sales and Marketing CVS, Mylan, epipen
The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …
Mylan launches $300 generic EpiPen to calm pricing controversy
December 16, 2016Sales and Marketing Mylan, epipen
Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …
Mylan to restructure and slash around 10% of workforce
December 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses
Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …
Mylan ducks call to testify in front of Senate
November 22, 2016Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen
Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …
Mylan agrees $465m settlement over EpiPen misclassification
October 10, 2016Business Services, Medical Communications, Sales and Marketing Heather Bresch, Mylan, Price hike, epipen
In the latest scandal in the EpiPen price hike saga, the US Department of Justice has made claims that the …
“Incorrect classification” of EpiPen leads to $1 billion bill for US government
October 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, Heather Bresch, Misclassification, Mylan, Price hike, classification, epipen, price, scandal
Mylan’s EpiPen woes show no sign of abating after CMS (Centers for Medicare and Medicaid Services) released figures that show …
Mylan’s promised half-price EpiPen not available until year’s end
October 5, 2016Research and Development, Sales and Marketing Mylan, epipen
Consumers may have to wait until the end of the year for the half-price EpiPen, months after Mylan originally promised …
Price-hiked EpiPen profits 66% higher than Mylan CEO claimed
September 27, 2016Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen
In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …
EpiPen CEO appears before US lawmakers to defend “sickening” price hikes
September 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen
Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …
Mylan CEO to appear before US congress over EpiPen scandal
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Hilary Clinton, Mylan, epipen
Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …
Top ten stories in the pharmaceutical industry this week
September 9, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, BMS, Celgene, Cloud Computing, Eisai, FDA, GSK, Halaven, Novartis, Novo Nordisk, Roche, Teva, agios, epipen, rheumatoid arthritis
It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …
Antitrust investigation launched into Mylan and the EpiPen scandal
September 7, 2016Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal
The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
